On early September 2023, Eurovisco held its annual consensus meeting gathering Europeans osteoarthritis experts.
This year’s aim was to determine the imaging and clinical criteria that influence the success rate of treatment of knee osteoarthritis by injection of an HA-based viscosupplement.
Dr Thierry Conrozier masterfully chaired this meeting and Labrha had the pleasure to sponsor this event again.
An article will soon be released gathering all the recommendations issued from this consensus meeting.
We will publish it on this page shortly.
Discover more about the EUROVISCO group by clicking here.